Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) FCF Margin (2016 - 2026)

Wave Life Sciences (WVE) has disclosed FCF Margin for 12 consecutive years, with 156.86% as the latest value for Q1 2026.

  • For Q1 2026, FCF Margin rose 53202.0% year-over-year to 156.86%; the TTM value through Mar 2026 reached 394.07%, down 31468.0%, while the annual FY2025 figure was 440.5%, 30018.0% down from the prior year.
  • FCF Margin hit 156.86% in Q1 2026 for Wave Life Sciences, up from 532.45% in the prior quarter.
  • Across five years, FCF Margin topped out at 657.69% in Q1 2023 and bottomed at 9158.95% in Q3 2022.
  • Average FCF Margin over 5 years is 1480.39%, with a median of 162.86% recorded in 2023.
  • Year-over-year, FCF Margin plummeted -908130bps in 2022 and then soared 908853bps in 2023.
  • Wave Life Sciences' FCF Margin stood at 41.43% in 2022, then skyrocketed by 37bps to 26.21% in 2023, then increased by 16bps to 21.92% in 2024, then crashed by -2329bps to 532.45% in 2025, then skyrocketed by 71bps to 156.86% in 2026.
  • According to Business Quant data, FCF Margin over the past three periods came in at 156.86%, 532.45%, and 688.87% for Q1 2026, Q2 2025, and Q1 2025 respectively.